Ragaey Ahmad Eid, Manar Ahmed Kamal, A. Attia, Aliaa Abdel Fattah, Rabab Afify Mohamed, M. Tawfik, A. Haseeb
{"title":"经皮射频消融治疗中期肝细胞癌的疗效和反应预测因素:一项对照临床试验","authors":"Ragaey Ahmad Eid, Manar Ahmed Kamal, A. Attia, Aliaa Abdel Fattah, Rabab Afify Mohamed, M. Tawfik, A. Haseeb","doi":"10.1136/gutjnl-2022-iddf.92","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IDDF2022-ABS-0058 Efficacy and response predictors of percutaneous radiofrequency ablation for treatment of intermediate stage hepatocellular carcinoma: a controlled clinical trial\",\"authors\":\"Ragaey Ahmad Eid, Manar Ahmed Kamal, A. Attia, Aliaa Abdel Fattah, Rabab Afify Mohamed, M. Tawfik, A. Haseeb\",\"doi\":\"10.1136/gutjnl-2022-iddf.92\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9921,\"journal\":{\"name\":\"Chinese Journal of Clinical Hepatology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chinese Journal of Clinical Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/gutjnl-2022-iddf.92\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Clinical Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/gutjnl-2022-iddf.92","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
IDDF2022-ABS-0058 Efficacy and response predictors of percutaneous radiofrequency ablation for treatment of intermediate stage hepatocellular carcinoma: a controlled clinical trial